PROVECTUS BIOPHARMACEUTICALS INC WTS (DE)
PVCT.WS
PVCT.WS was delisted on the 13th of October, 2016.
2 hedge funds and large institutions have $675K invested in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
21% less capital invested
Capital invested by funds: $856K → $675K (-$181K)
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $550K | – | – | – |
|
2
Millennium Management
New York
| $125K | – | – | – |
|
PVCT.WS Hedge Fund Activity: Q4 2015 in Review
2 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) for Q4 2015, worth a combined $675K — down 21% from $856K a quarter earlier.
Fund positioning in PVCT.WS was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 2 institutional investors held PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $675K of PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) stock for Q4 2015, down 21% quarter-over-quarter.
- 0 funds opened new PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) positions in Q4 2015 and 0 closed out.
Based on aggregated 13F filings for Q4 2015.